Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia-Reference-Cited by-同舟云学术

Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia

Published:2011 Issue:s1 Volume:81 Page:158-164
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Han Kwang-Hyub,Kudo Masatochi,Ye Sheng-Long,Choi Jong Young,Poon Roonni Tung-Ping,Seong Jinsil,Park Joong-Won,Ichida Takafumi,Chung Jin Wook,Chow Pierce,Cheng Ann-Lii

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference29 articles.

1. Liver Cancer Working Group Report

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

4. Prognostic prediction and treatment strategy in hepatocellular carcinoma

5. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma;Surgery;2024-07

2. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis;Frontiers in Immunology;2024-01-08

3. Liver Cancer;Tata Memorial Centre Textbook of Oncology;2024

4. Management of Hepatocellular Carcinoma: The East-West Difference;Current Chinese Science;2023-12

5. Adjuvant Lenvatinib in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma Patients with High-Risk of Postoperative Recurrence: A Prospective Cohort Study;2023-07-18